Tumor necrosis factor-alpha gene −308G>A polymorphism is associated with ST-elevation myocardial infarction and with high plasma levels of biochemical ischemia markers
OBJECTIVESAs is well known, acute myocardial infarction presents two electrocardiogram (EKG) patterns, ST-elevation (STEMI) and no ST-elevation (NSTEMI), characterized by different coronary artery thrombotic occlusion. Growing evidence shows that inflammation plays a central role in the pathogenesis...
Gespeichert in:
Veröffentlicht in: | Coronary artery disease 2005-12, Vol.16 (8), p.489-493 |
---|---|
Hauptverfasser: | , , , , , , , , , , |
Format: | Artikel |
Sprache: | eng |
Schlagworte: | |
Online-Zugang: | Volltext |
Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|
container_end_page | 493 |
---|---|
container_issue | 8 |
container_start_page | 489 |
container_title | Coronary artery disease |
container_volume | 16 |
creator | Antonicelli, Roberto Olivieri, Fabiola Cavallone, Luca Spazzafumo, Liana Bonafè, Massimiliano Marchegiani, Francesca Cardelli, Maurizio Galeazzi, Roberta Giovagnetti, Simona Perna, Gian Piero Franceschi, Claudio |
description | OBJECTIVESAs is well known, acute myocardial infarction presents two electrocardiogram (EKG) patterns, ST-elevation (STEMI) and no ST-elevation (NSTEMI), characterized by different coronary artery thrombotic occlusion. Growing evidence shows that inflammation plays a central role in the pathogenesis of acute myocardial infarction. Among the factors that promote inflammation and arterial thrombosis, one of the most important is the proinflammatory cytokine tumor necrosis factor-α. The expression of this cytokine is modulated by a polymorphism located at nucleotide −308 of tumor necrosis factor-α promoter gene. The objective of our study is to verify whether tumor necrosis factor-α −308 polymorphism is associated with risk of acute myocardial infarction (STEMI and NSTEMI) or with biochemical myocardial ischemia markers, such as troponin I, creatine kinase-MB, lactate dehydrogenase and myoglobin.
METHODSWe analyzed tumor necrosis factor-α −308 polymorphism in a total of 603 study participants293 elderly patients affected by acute myocardial infarction (STEMI and NSTEMI) and 310 healthy controls.
RESULTSWe found that individuals carrying the tumor necrosis factor-α −308 AG+AA genotypes are significantly more represented among acute myocardial infarction patients affected by STEMI than among NSTEMI patients (OR=1.86, 95% CI 1.08–3.21, p=0.027) and healthy controls (OR=1.64, 95% CI 1.03–2.64, p=0.046). Furthermore, the patients carrying tumor necrosis factor-α −308 AG+AA genotypes displayed significant increased levels of biochemical myocardial ischemia markers.
CONCLUSIONSOur study shows a significant association between the tumor necrosis factor-α −308 polymorphism and the occurrence of STEMI, and suggests that the tumor necrosis factor-α −308 polymorphism could play a role in the pathogenesis of cardiac ischemic damage, AA+AG genotype carrier individuals being likely to be affected by more severe ischemic damage than the rest of the population. |
doi_str_mv | 10.1097/00019501-200512000-00006 |
format | Article |
fullrecord | <record><control><sourceid>proquest_cross</sourceid><recordid>TN_cdi_proquest_miscellaneous_68851777</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>68851777</sourcerecordid><originalsourceid>FETCH-LOGICAL-c3586-9752f0cb07d2f18cc1a00bf1ac51d54b29dcc600c415bbf514dffba31a3077ba3</originalsourceid><addsrcrecordid>eNp1kc-O1SAUh4nRONfRVzCs3KGHtpR2YzKZOKPJJC68rskphSkOLRVab-4buPYtfC2fRO4fdeUCOCHfDw58hFAOrzm08g0A8FYAZwWA4HkClgfUj8iGV7JkoinhMdlAKypWt0VzQZ6l9CWHKiHFU3LB65K3tWg35Od2HUOkk9ExJJeoRb2EyNDPA9J7Mxn66_uPEprbt1d0Dn6f4XlwaaSZxZSCdriYnu7cMtBPW2a8-YaLCxMd90Fj7B166iaLUR93cTqzg7sf6OwxjUhzxvhEg6WdC3owo9OHVDqWSEeMDyam5-SJRZ_Mi_N6ST7fvNtev2d3H28_XF_dMV2KpmatFIUF3YHsC8sbrTkCdJajFrwXVVe0vdY1gK646DoreNVb22HJsQQpc3FJXp3OnWP4upq0qDG3YrzHyYQ1qbppBJdSZrA5gYevS9FYNUeXm90rDuqgSf3RpP5qUkdNOfryfMfajab_Fzx7yUB1AnbBL_nxD37dmagGg34Z1P_0l78B3zWh4A</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>68851777</pqid></control><display><type>article</type><title>Tumor necrosis factor-alpha gene −308G>A polymorphism is associated with ST-elevation myocardial infarction and with high plasma levels of biochemical ischemia markers</title><source>MEDLINE</source><source>Journals@Ovid Complete</source><creator>Antonicelli, Roberto ; Olivieri, Fabiola ; Cavallone, Luca ; Spazzafumo, Liana ; Bonafè, Massimiliano ; Marchegiani, Francesca ; Cardelli, Maurizio ; Galeazzi, Roberta ; Giovagnetti, Simona ; Perna, Gian Piero ; Franceschi, Claudio</creator><creatorcontrib>Antonicelli, Roberto ; Olivieri, Fabiola ; Cavallone, Luca ; Spazzafumo, Liana ; Bonafè, Massimiliano ; Marchegiani, Francesca ; Cardelli, Maurizio ; Galeazzi, Roberta ; Giovagnetti, Simona ; Perna, Gian Piero ; Franceschi, Claudio</creatorcontrib><description>OBJECTIVESAs is well known, acute myocardial infarction presents two electrocardiogram (EKG) patterns, ST-elevation (STEMI) and no ST-elevation (NSTEMI), characterized by different coronary artery thrombotic occlusion. Growing evidence shows that inflammation plays a central role in the pathogenesis of acute myocardial infarction. Among the factors that promote inflammation and arterial thrombosis, one of the most important is the proinflammatory cytokine tumor necrosis factor-α. The expression of this cytokine is modulated by a polymorphism located at nucleotide −308 of tumor necrosis factor-α promoter gene. The objective of our study is to verify whether tumor necrosis factor-α −308 polymorphism is associated with risk of acute myocardial infarction (STEMI and NSTEMI) or with biochemical myocardial ischemia markers, such as troponin I, creatine kinase-MB, lactate dehydrogenase and myoglobin.
METHODSWe analyzed tumor necrosis factor-α −308 polymorphism in a total of 603 study participants293 elderly patients affected by acute myocardial infarction (STEMI and NSTEMI) and 310 healthy controls.
RESULTSWe found that individuals carrying the tumor necrosis factor-α −308 AG+AA genotypes are significantly more represented among acute myocardial infarction patients affected by STEMI than among NSTEMI patients (OR=1.86, 95% CI 1.08–3.21, p=0.027) and healthy controls (OR=1.64, 95% CI 1.03–2.64, p=0.046). Furthermore, the patients carrying tumor necrosis factor-α −308 AG+AA genotypes displayed significant increased levels of biochemical myocardial ischemia markers.
CONCLUSIONSOur study shows a significant association between the tumor necrosis factor-α −308 polymorphism and the occurrence of STEMI, and suggests that the tumor necrosis factor-α −308 polymorphism could play a role in the pathogenesis of cardiac ischemic damage, AA+AG genotype carrier individuals being likely to be affected by more severe ischemic damage than the rest of the population.</description><identifier>ISSN: 0954-6928</identifier><identifier>EISSN: 1473-5830</identifier><identifier>DOI: 10.1097/00019501-200512000-00006</identifier><identifier>PMID: 16319659</identifier><language>eng</language><publisher>England: Lippincott Williams & Wilkins, Inc</publisher><subject>Aged ; Aged, 80 and over ; Biomarkers - blood ; Creatine Kinase, MB Form - blood ; Electrocardiography ; Female ; Humans ; L-Lactate Dehydrogenase - blood ; Male ; Myocardial Infarction - genetics ; Myocardial Infarction - physiopathology ; Myocardial Ischemia - genetics ; Myocardial Ischemia - physiopathology ; Myoglobin - blood ; Polymorphism, Genetic ; Risk Factors ; Troponin I - blood ; Tumor Necrosis Factor-alpha - genetics</subject><ispartof>Coronary artery disease, 2005-12, Vol.16 (8), p.489-493</ispartof><rights>2005 Lippincott Williams & Wilkins, Inc.</rights><lds50>peer_reviewed</lds50><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c3586-9752f0cb07d2f18cc1a00bf1ac51d54b29dcc600c415bbf514dffba31a3077ba3</citedby><cites>FETCH-LOGICAL-c3586-9752f0cb07d2f18cc1a00bf1ac51d54b29dcc600c415bbf514dffba31a3077ba3</cites></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><link.rule.ids>314,776,780,27901,27902</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/16319659$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Antonicelli, Roberto</creatorcontrib><creatorcontrib>Olivieri, Fabiola</creatorcontrib><creatorcontrib>Cavallone, Luca</creatorcontrib><creatorcontrib>Spazzafumo, Liana</creatorcontrib><creatorcontrib>Bonafè, Massimiliano</creatorcontrib><creatorcontrib>Marchegiani, Francesca</creatorcontrib><creatorcontrib>Cardelli, Maurizio</creatorcontrib><creatorcontrib>Galeazzi, Roberta</creatorcontrib><creatorcontrib>Giovagnetti, Simona</creatorcontrib><creatorcontrib>Perna, Gian Piero</creatorcontrib><creatorcontrib>Franceschi, Claudio</creatorcontrib><title>Tumor necrosis factor-alpha gene −308G>A polymorphism is associated with ST-elevation myocardial infarction and with high plasma levels of biochemical ischemia markers</title><title>Coronary artery disease</title><addtitle>Coron Artery Dis</addtitle><description>OBJECTIVESAs is well known, acute myocardial infarction presents two electrocardiogram (EKG) patterns, ST-elevation (STEMI) and no ST-elevation (NSTEMI), characterized by different coronary artery thrombotic occlusion. Growing evidence shows that inflammation plays a central role in the pathogenesis of acute myocardial infarction. Among the factors that promote inflammation and arterial thrombosis, one of the most important is the proinflammatory cytokine tumor necrosis factor-α. The expression of this cytokine is modulated by a polymorphism located at nucleotide −308 of tumor necrosis factor-α promoter gene. The objective of our study is to verify whether tumor necrosis factor-α −308 polymorphism is associated with risk of acute myocardial infarction (STEMI and NSTEMI) or with biochemical myocardial ischemia markers, such as troponin I, creatine kinase-MB, lactate dehydrogenase and myoglobin.
METHODSWe analyzed tumor necrosis factor-α −308 polymorphism in a total of 603 study participants293 elderly patients affected by acute myocardial infarction (STEMI and NSTEMI) and 310 healthy controls.
RESULTSWe found that individuals carrying the tumor necrosis factor-α −308 AG+AA genotypes are significantly more represented among acute myocardial infarction patients affected by STEMI than among NSTEMI patients (OR=1.86, 95% CI 1.08–3.21, p=0.027) and healthy controls (OR=1.64, 95% CI 1.03–2.64, p=0.046). Furthermore, the patients carrying tumor necrosis factor-α −308 AG+AA genotypes displayed significant increased levels of biochemical myocardial ischemia markers.
CONCLUSIONSOur study shows a significant association between the tumor necrosis factor-α −308 polymorphism and the occurrence of STEMI, and suggests that the tumor necrosis factor-α −308 polymorphism could play a role in the pathogenesis of cardiac ischemic damage, AA+AG genotype carrier individuals being likely to be affected by more severe ischemic damage than the rest of the population.</description><subject>Aged</subject><subject>Aged, 80 and over</subject><subject>Biomarkers - blood</subject><subject>Creatine Kinase, MB Form - blood</subject><subject>Electrocardiography</subject><subject>Female</subject><subject>Humans</subject><subject>L-Lactate Dehydrogenase - blood</subject><subject>Male</subject><subject>Myocardial Infarction - genetics</subject><subject>Myocardial Infarction - physiopathology</subject><subject>Myocardial Ischemia - genetics</subject><subject>Myocardial Ischemia - physiopathology</subject><subject>Myoglobin - blood</subject><subject>Polymorphism, Genetic</subject><subject>Risk Factors</subject><subject>Troponin I - blood</subject><subject>Tumor Necrosis Factor-alpha - genetics</subject><issn>0954-6928</issn><issn>1473-5830</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2005</creationdate><recordtype>article</recordtype><sourceid>EIF</sourceid><recordid>eNp1kc-O1SAUh4nRONfRVzCs3KGHtpR2YzKZOKPJJC68rskphSkOLRVab-4buPYtfC2fRO4fdeUCOCHfDw58hFAOrzm08g0A8FYAZwWA4HkClgfUj8iGV7JkoinhMdlAKypWt0VzQZ6l9CWHKiHFU3LB65K3tWg35Od2HUOkk9ExJJeoRb2EyNDPA9J7Mxn66_uPEprbt1d0Dn6f4XlwaaSZxZSCdriYnu7cMtBPW2a8-YaLCxMd90Fj7B166iaLUR93cTqzg7sf6OwxjUhzxvhEg6WdC3owo9OHVDqWSEeMDyam5-SJRZ_Mi_N6ST7fvNtev2d3H28_XF_dMV2KpmatFIUF3YHsC8sbrTkCdJajFrwXVVe0vdY1gK646DoreNVb22HJsQQpc3FJXp3OnWP4upq0qDG3YrzHyYQ1qbppBJdSZrA5gYevS9FYNUeXm90rDuqgSf3RpP5qUkdNOfryfMfajab_Fzx7yUB1AnbBL_nxD37dmagGg34Z1P_0l78B3zWh4A</recordid><startdate>200512</startdate><enddate>200512</enddate><creator>Antonicelli, Roberto</creator><creator>Olivieri, Fabiola</creator><creator>Cavallone, Luca</creator><creator>Spazzafumo, Liana</creator><creator>Bonafè, Massimiliano</creator><creator>Marchegiani, Francesca</creator><creator>Cardelli, Maurizio</creator><creator>Galeazzi, Roberta</creator><creator>Giovagnetti, Simona</creator><creator>Perna, Gian Piero</creator><creator>Franceschi, Claudio</creator><general>Lippincott Williams & Wilkins, Inc</general><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>7X8</scope></search><sort><creationdate>200512</creationdate><title>Tumor necrosis factor-alpha gene −308G>A polymorphism is associated with ST-elevation myocardial infarction and with high plasma levels of biochemical ischemia markers</title><author>Antonicelli, Roberto ; Olivieri, Fabiola ; Cavallone, Luca ; Spazzafumo, Liana ; Bonafè, Massimiliano ; Marchegiani, Francesca ; Cardelli, Maurizio ; Galeazzi, Roberta ; Giovagnetti, Simona ; Perna, Gian Piero ; Franceschi, Claudio</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c3586-9752f0cb07d2f18cc1a00bf1ac51d54b29dcc600c415bbf514dffba31a3077ba3</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2005</creationdate><topic>Aged</topic><topic>Aged, 80 and over</topic><topic>Biomarkers - blood</topic><topic>Creatine Kinase, MB Form - blood</topic><topic>Electrocardiography</topic><topic>Female</topic><topic>Humans</topic><topic>L-Lactate Dehydrogenase - blood</topic><topic>Male</topic><topic>Myocardial Infarction - genetics</topic><topic>Myocardial Infarction - physiopathology</topic><topic>Myocardial Ischemia - genetics</topic><topic>Myocardial Ischemia - physiopathology</topic><topic>Myoglobin - blood</topic><topic>Polymorphism, Genetic</topic><topic>Risk Factors</topic><topic>Troponin I - blood</topic><topic>Tumor Necrosis Factor-alpha - genetics</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Antonicelli, Roberto</creatorcontrib><creatorcontrib>Olivieri, Fabiola</creatorcontrib><creatorcontrib>Cavallone, Luca</creatorcontrib><creatorcontrib>Spazzafumo, Liana</creatorcontrib><creatorcontrib>Bonafè, Massimiliano</creatorcontrib><creatorcontrib>Marchegiani, Francesca</creatorcontrib><creatorcontrib>Cardelli, Maurizio</creatorcontrib><creatorcontrib>Galeazzi, Roberta</creatorcontrib><creatorcontrib>Giovagnetti, Simona</creatorcontrib><creatorcontrib>Perna, Gian Piero</creatorcontrib><creatorcontrib>Franceschi, Claudio</creatorcontrib><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>MEDLINE - Academic</collection><jtitle>Coronary artery disease</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Antonicelli, Roberto</au><au>Olivieri, Fabiola</au><au>Cavallone, Luca</au><au>Spazzafumo, Liana</au><au>Bonafè, Massimiliano</au><au>Marchegiani, Francesca</au><au>Cardelli, Maurizio</au><au>Galeazzi, Roberta</au><au>Giovagnetti, Simona</au><au>Perna, Gian Piero</au><au>Franceschi, Claudio</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Tumor necrosis factor-alpha gene −308G>A polymorphism is associated with ST-elevation myocardial infarction and with high plasma levels of biochemical ischemia markers</atitle><jtitle>Coronary artery disease</jtitle><addtitle>Coron Artery Dis</addtitle><date>2005-12</date><risdate>2005</risdate><volume>16</volume><issue>8</issue><spage>489</spage><epage>493</epage><pages>489-493</pages><issn>0954-6928</issn><eissn>1473-5830</eissn><abstract>OBJECTIVESAs is well known, acute myocardial infarction presents two electrocardiogram (EKG) patterns, ST-elevation (STEMI) and no ST-elevation (NSTEMI), characterized by different coronary artery thrombotic occlusion. Growing evidence shows that inflammation plays a central role in the pathogenesis of acute myocardial infarction. Among the factors that promote inflammation and arterial thrombosis, one of the most important is the proinflammatory cytokine tumor necrosis factor-α. The expression of this cytokine is modulated by a polymorphism located at nucleotide −308 of tumor necrosis factor-α promoter gene. The objective of our study is to verify whether tumor necrosis factor-α −308 polymorphism is associated with risk of acute myocardial infarction (STEMI and NSTEMI) or with biochemical myocardial ischemia markers, such as troponin I, creatine kinase-MB, lactate dehydrogenase and myoglobin.
METHODSWe analyzed tumor necrosis factor-α −308 polymorphism in a total of 603 study participants293 elderly patients affected by acute myocardial infarction (STEMI and NSTEMI) and 310 healthy controls.
RESULTSWe found that individuals carrying the tumor necrosis factor-α −308 AG+AA genotypes are significantly more represented among acute myocardial infarction patients affected by STEMI than among NSTEMI patients (OR=1.86, 95% CI 1.08–3.21, p=0.027) and healthy controls (OR=1.64, 95% CI 1.03–2.64, p=0.046). Furthermore, the patients carrying tumor necrosis factor-α −308 AG+AA genotypes displayed significant increased levels of biochemical myocardial ischemia markers.
CONCLUSIONSOur study shows a significant association between the tumor necrosis factor-α −308 polymorphism and the occurrence of STEMI, and suggests that the tumor necrosis factor-α −308 polymorphism could play a role in the pathogenesis of cardiac ischemic damage, AA+AG genotype carrier individuals being likely to be affected by more severe ischemic damage than the rest of the population.</abstract><cop>England</cop><pub>Lippincott Williams & Wilkins, Inc</pub><pmid>16319659</pmid><doi>10.1097/00019501-200512000-00006</doi><tpages>5</tpages></addata></record> |
fulltext | fulltext |
identifier | ISSN: 0954-6928 |
ispartof | Coronary artery disease, 2005-12, Vol.16 (8), p.489-493 |
issn | 0954-6928 1473-5830 |
language | eng |
recordid | cdi_proquest_miscellaneous_68851777 |
source | MEDLINE; Journals@Ovid Complete |
subjects | Aged Aged, 80 and over Biomarkers - blood Creatine Kinase, MB Form - blood Electrocardiography Female Humans L-Lactate Dehydrogenase - blood Male Myocardial Infarction - genetics Myocardial Infarction - physiopathology Myocardial Ischemia - genetics Myocardial Ischemia - physiopathology Myoglobin - blood Polymorphism, Genetic Risk Factors Troponin I - blood Tumor Necrosis Factor-alpha - genetics |
title | Tumor necrosis factor-alpha gene −308G>A polymorphism is associated with ST-elevation myocardial infarction and with high plasma levels of biochemical ischemia markers |
url | https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-02-13T08%3A10%3A42IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_cross&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Tumor%20necrosis%20factor-alpha%20gene%20%E2%88%92308G%3EA%20polymorphism%20is%20associated%20with%20ST-elevation%20myocardial%20infarction%20and%20with%20high%20plasma%20levels%20of%20biochemical%20ischemia%20markers&rft.jtitle=Coronary%20artery%20disease&rft.au=Antonicelli,%20Roberto&rft.date=2005-12&rft.volume=16&rft.issue=8&rft.spage=489&rft.epage=493&rft.pages=489-493&rft.issn=0954-6928&rft.eissn=1473-5830&rft_id=info:doi/10.1097/00019501-200512000-00006&rft_dat=%3Cproquest_cross%3E68851777%3C/proquest_cross%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_pqid=68851777&rft_id=info:pmid/16319659&rfr_iscdi=true |